• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EB 病毒 BZLF1 蛋白的 SUMO 化抑制其转录活性,并受病毒编码的蛋白激酶调节。

Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.

机构信息

McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, 1400 University Ave., Madison, WI 53706, USA.

出版信息

J Virol. 2010 May;84(9):4383-94. doi: 10.1128/JVI.02369-09. Epub 2010 Feb 24.

DOI:10.1128/JVI.02369-09
PMID:20181712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2863741/
Abstract

The Epstein-Barr virus (EBV) immediate-early protein BZLF1 (Z) mediates the switch between latent and lytic EBV infection. Z not only activates early lytic viral gene transcription but also plays a direct role in lytic viral genome replication. Although a small fraction of Z is known to be sumoylated, the effects of this posttranslational modification on various different Z functions have not been well defined. In this report, we show that only the lysine at amino acid residue 12 is required for the sumoylation of Z, and that Z can be sumoylated by SUMO isoforms 1, 2, and 3. We also demonstrate that the sumo-defective Z mutants ZK12A and ZK12R have enhanced transcriptional activity. The sumoylated and nonsumoylated forms of Z were found to have a similar cellular location, both being localized primarily within the nuclear matrix. The Z sumo-defective mutants were, however, partially defective for disrupting promyelocytic leukemia (PML) bodies compared to the ability of wild-type Z. In addition, we show that lytic viral genome replication does not require the sumoylation of Z, although a Z mutant altered at both amino acids 12 and 13 is replication defective. Furthermore, we show that the sumoylation of Z is greatly increased (from less than 1 to about 11%) in lytically induced 293 cells infected with an EBV mutant virus deleted for the EBV-encoded protein kinase (EBV-PK) compared to that of 293 cells infected with wild-type EBV, and that the overexpression of EBV-PK leads to the reduced sumoylation of Z in EBV-negative cells. Our results suggest that the sumoylation of Z helps to promote viral latency, and that EBV-PK inhibits Z sumoylation during viral reactivation.

摘要

EBV 立即早期蛋白 BZLF1(Z)介导潜伏和裂解 EBV 感染之间的转换。Z 不仅激活早期裂解病毒基因转录,而且在裂解病毒基因组复制中发挥直接作用。虽然已知 Z 的一小部分被 SUMO 化,但这种翻译后修饰对各种不同 Z 功能的影响尚未得到很好的定义。在本报告中,我们表明只有氨基酸残基 12 上的赖氨酸是 Z 发生 SUMO 化所必需的,并且 Z 可以被 SUMO 同种型 1、2 和 3 进行 SUMO 化。我们还证明,SUMO 缺陷型 Z 突变体 ZK12A 和 ZK12R 具有增强的转录活性。SUMO 化和非 SUMO 化形式的 Z 被发现具有相似的细胞定位,两者主要位于核基质内。与野生型 Z 相比,SUMO 缺陷型 Z 突变体在破坏早幼粒细胞白血病(PML)体方面仅部分缺陷。此外,我们表明裂解病毒基因组复制不需要 Z 的 SUMO 化,尽管在氨基酸 12 和 13 处均发生突变的 Z 突变体是复制缺陷的。此外,我们表明,与感染野生型 EBV 的 293 细胞相比,在感染缺失 EBV 编码蛋白激酶(EBV-PK)的 EBV 突变病毒的裂解诱导的 293 细胞中,Z 的 SUMO 化大大增加(从少于 1%增加到约 11%),并且 EBV-PK 的过表达导致 EBV 阴性细胞中 Z 的 SUMO 化减少。我们的结果表明,Z 的 SUMO 化有助于促进病毒潜伏,并且 EBV-PK 在病毒重新激活期间抑制 Z 的 SUMO 化。

相似文献

1
Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.EB 病毒 BZLF1 蛋白的 SUMO 化抑制其转录活性,并受病毒编码的蛋白激酶调节。
J Virol. 2010 May;84(9):4383-94. doi: 10.1128/JVI.02369-09. Epub 2010 Feb 24.
2
Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.爱泼斯坦-巴尔病毒即刻早期蛋白BZLF1经小泛素样修饰蛋白1修饰并破坏早幼粒细胞白血病小体。
J Virol. 2001 Mar;75(5):2388-99. doi: 10.1128/JVI.75.5.2388-2399.2001.
3
The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.B 细胞特异性转录因子 Oct-2 通过抑制 EBV 即刻早期蛋白 BZLF1 促进 EBV 潜伏期。
PLoS Pathog. 2012 Feb;8(2):e1002516. doi: 10.1371/journal.ppat.1002516. Epub 2012 Feb 9.
4
Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.细胞分化调节因子BLIMP1通过激活R和Z启动子的转录,诱导上皮细胞和B细胞中的爱泼斯坦-巴尔病毒裂解性再激活。
J Virol. 2015 Feb;89(3):1731-43. doi: 10.1128/JVI.02781-14. Epub 2014 Nov 19.
5
Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.靶向潜伏和诱导性 Epstein-Barr 病毒感染过程中的 SUMO 化作用,使用小分子抑制剂 ML-792。
Antiviral Res. 2021 Apr;188:105038. doi: 10.1016/j.antiviral.2021.105038. Epub 2021 Feb 10.
6
Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta.泛素化修饰 Epstein-Barr 病毒即刻早期转录激活子 Zta。
J Virol. 2020 Oct 27;94(22). doi: 10.1128/JVI.01298-20.
7
LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.LMP1诱导的类泛素化修饰通过KAP1影响爱泼斯坦-巴尔病毒潜伏感染的维持。
J Virol. 2015 Aug;89(15):7465-77. doi: 10.1128/JVI.00711-15. Epub 2015 May 6.
8
Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression.爱泼斯坦-巴尔病毒(EBV)的SM蛋白诱导并招募细胞Sp110b以稳定信使核糖核酸(mRNA)并增强EBV裂解基因的表达。
J Virol. 2004 Sep;78(17):9412-22. doi: 10.1128/JVI.78.17.9412-9422.2004.
9
Transcriptional repression by sumoylation of Epstein-Barr virus BZLF1 protein correlates with association of histone deacetylase.BZLF1 蛋白的 SUMO 化转录抑制与组蛋白去乙酰化酶的关联有关。
J Biol Chem. 2010 Jul 30;285(31):23925-35. doi: 10.1074/jbc.M109.095356. Epub 2010 Jun 1.
10
BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.BZLF1对BRLF1即刻早期启动子甲基化形式的激活受BZLF1第186位残基调控。
J Virol. 2005 Jun;79(12):7338-48. doi: 10.1128/JVI.79.12.7338-7348.2005.

引用本文的文献

1
Identifying the key regulators orchestrating Epstein-Barr virus reactivation.确定调控爱泼斯坦-巴尔病毒重新激活的关键调节因子。
Front Microbiol. 2024 Dec 5;15:1505191. doi: 10.3389/fmicb.2024.1505191. eCollection 2024.
2
Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1.EB 病毒感染中 SUMO 修饰蛋白的变化鉴定了 TRIM24/28/33 复合物和裂解开关 BZLF1 的相互调节。
PLoS Pathog. 2023 Jul 6;19(7):e1011477. doi: 10.1371/journal.ppat.1011477. eCollection 2023 Jul.
3
Mechanism of herpesvirus protein kinase UL13 in immune escape and viral replication.疱疹病毒蛋白激酶 UL13 在免疫逃避和病毒复制中的作用机制。
Front Immunol. 2022 Nov 30;13:1088690. doi: 10.3389/fimmu.2022.1088690. eCollection 2022.
4
Functional diversity: update of the posttranslational modification of Epstein-Barr virus coding proteins.功能多样性:EB 病毒编码蛋白翻译后修饰的更新。
Cell Mol Life Sci. 2022 Nov 14;79(12):590. doi: 10.1007/s00018-022-04561-2.
5
SUMOylation in Viral Replication and Antiviral Defense.SUMOylation 在病毒复制和抗病毒防御中的作用。
Adv Sci (Weinh). 2022 Mar;9(7):e2104126. doi: 10.1002/advs.202104126. Epub 2022 Jan 21.
6
Conserved E1B-55K SUMOylation in Different Human Adenovirus Species Is a Potent Regulator of Intracellular Localization.不同型人腺病毒中保守的 E1B-55K SUMOylation 是一种有效的细胞内定位调节剂。
J Virol. 2022 Feb 9;96(3):e0083821. doi: 10.1128/JVI.00838-21. Epub 2021 Nov 17.
7
A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity.篡夺与颠覆的故事:在感染与免疫的十字路口,早幼粒细胞白血病核体依赖小泛素样修饰物的完整性
Front Cell Dev Biol. 2021 Aug 27;9:696234. doi: 10.3389/fcell.2021.696234. eCollection 2021.
8
SUMO and SUMOylation Pathway at the Forefront of Host Immune Response.小泛素样修饰蛋白(SUMO)及SUMO化途径处于宿主免疫反应前沿
Front Cell Dev Biol. 2021 Jul 14;9:681057. doi: 10.3389/fcell.2021.681057. eCollection 2021.
9
Oncogenic Properties of the EBV ZEBRA Protein.EBV ZEBRA蛋白的致癌特性
Cancers (Basel). 2020 Jun 5;12(6):1479. doi: 10.3390/cancers12061479.
10
The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease.EB 病毒致癌蛋白,LMP1,调节 SUMO 蛋白酶 SENP2 的功能。
Sci Rep. 2019 Jul 2;9(1):9523. doi: 10.1038/s41598-019-45825-5.

本文引用的文献

1
SUMOylation of DRIL1 directs its transcriptional activity towards leukocyte lineage-specific genes.DRIL1的类泛素化修饰将其转录活性导向白细胞谱系特异性基因。
PLoS One. 2009;4(5):e5542. doi: 10.1371/journal.pone.0005542. Epub 2009 May 14.
2
Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters.爱泼斯坦-巴尔病毒BZLF1蛋白与病毒启动子的甲基化依赖性结合。
PLoS Pathog. 2009 Mar;5(3):e1000356. doi: 10.1371/journal.ppat.1000356. Epub 2009 Mar 27.
3
Epstein-Barr virus protein kinase BGLF4 interacts with viral transactivator BZLF1 and regulates its transactivation activity.爱泼斯坦-巴尔病毒蛋白激酶BGLF4与病毒反式激活因子BZLF1相互作用,并调节其反式激活活性。
J Gen Virol. 2009 Jul;90(Pt 7):1575-1581. doi: 10.1099/vir.0.010462-0. Epub 2009 Mar 25.
4
The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1.爱泼斯坦-巴尔病毒裂解周期激活因子Zta与宿主靶基因egr1启动子中的甲基化ZRE相互作用。
J Gen Virol. 2009 Jun;90(Pt 6):1450-1454. doi: 10.1099/vir.0.007922-0. Epub 2009 Mar 4.
5
Interaction of Epstein-Barr virus BZLF1 C-terminal tail structure and core zipper is required for DNA replication but not for promoter transactivation.爱泼斯坦-巴尔病毒BZLF1 C末端尾巴结构与核心拉链的相互作用是DNA复制所必需的,但不是启动子反式激活所必需的。
J Virol. 2009 Apr;83(7):3397-401. doi: 10.1128/JVI.02500-08. Epub 2009 Jan 14.
6
The reversal of epigenetic silencing of the EBV genome is regulated by viral bZIP protein.EBV基因组表观遗传沉默的逆转由病毒bZIP蛋白调控。
Biochem Soc Trans. 2008 Aug;36(Pt 4):637-9. doi: 10.1042/BST0360637.
7
The Epstein-Barr virus LF2 protein inhibits viral replication.爱泼斯坦-巴尔病毒LF2蛋白可抑制病毒复制。
J Virol. 2008 Sep;82(17):8509-19. doi: 10.1128/JVI.00315-08. Epub 2008 Jun 18.
8
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.RNF4是一种多聚SUMO特异性E3泛素连接酶,是砷诱导的PML降解所必需的。
Nat Cell Biol. 2008 May;10(5):538-46. doi: 10.1038/ncb1716. Epub 2008 Apr 13.
9
Nuclear organization and chromatin dynamics--Sp1, Sp3 and histone deacetylases.核组织与染色质动力学——Sp1、Sp3与组蛋白去乙酰化酶
Adv Enzyme Regul. 2008;48:189-208. doi: 10.1016/j.advenzreg.2007.11.016. Epub 2008 Mar 14.
10
ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus.锌指蛋白E盒结合因子1(ZEB1)在爱泼斯坦-巴尔病毒感染过程中调控潜伏-裂解转换。
PLoS Pathog. 2007 Dec;3(12):e194. doi: 10.1371/journal.ppat.0030194.